125 related articles for article (PubMed ID: 1108778)
1. Treatment of respiratory Klebsiella pneumoniae infection in mice with aerosols of kanamycin.
Berendt RF; Long GG; Walker JS
Antimicrob Agents Chemother; 1975 Nov; 8(5):585-90. PubMed ID: 1108778
[TBL] [Abstract][Full Text] [Related]
2. Protection against Klebsiella pneumoniae respiratory tract infection of mice and squirrel monkeys given kanamycin by aerosol and injection.
Berendt RF; Schneider MA; Young HW; Frola FR
Am J Vet Res; 1979 Sep; 40(9):1231-5. PubMed ID: 118692
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Klebsiella pneumoniae respiratory tract infection of squirrel monkeys with aerosol administration of kanamycin.
Berendt RF; Magruder RD; Frola FR
Am J Vet Res; 1980 Sep; 41(9):1492-4. PubMed ID: 7004284
[TBL] [Abstract][Full Text] [Related]
4. Experimental respiratory tract infection with Klebsiella pneumoniae DT-S in mice: chemotherapy with kanamycin.
Nishi T; Tsuchiya K
Antimicrob Agents Chemother; 1980 Mar; 17(3):494-505. PubMed ID: 6999983
[TBL] [Abstract][Full Text] [Related]
5. [Comparative study of the effect of inhalation and subcutaneous methods of administration of kanamycin during treatment and prevention of experimental pneumonia in albino mice].
Prokhorova II
Antibiotiki; 1968 Jun; 13(6):529-33. PubMed ID: 5678109
[No Abstract] [Full Text] [Related]
6. Evaluation of ceftazidime in experimental Klebsiella pneumoniae pneumonia: comparison with other antibiotics and measurement of its penetration into respiratory tissues and secretions.
McColm AA; Shelley E; Ryan DM; Acred P
J Antimicrob Chemother; 1986 Nov; 18(5):599-608. PubMed ID: 3542926
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial polymers as therapeutics for treatment of multidrug-resistant Klebsiella pneumoniae lung infection.
Lou W; Venkataraman S; Zhong G; Ding B; Tan JPK; Xu L; Fan W; Yang YY
Acta Biomater; 2018 Sep; 78():78-88. PubMed ID: 30031912
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effects of cefotiam and cefazolin on experimental pneumonia caused by Klebsiella pneumoniae DT-S in mice.
Nishi T; Tsuchiya K
Antimicrob Agents Chemother; 1980 Oct; 18(4):549-56. PubMed ID: 7004342
[TBL] [Abstract][Full Text] [Related]
9. [Inhalation therapy of antibiotics].
Noguchi Y; Taguchi M; Takasugi M; Sakamoto T; Matsumoto K
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Nov; 28(11):1432-5. PubMed ID: 2290226
[TBL] [Abstract][Full Text] [Related]
10. [A case of Klebsiella pneumonia with complication of CO2-narcosis successfully treated with amikacin (author's transl)].
Nakagami K; Yatani Y; Osakabe Y; Kunieda T; Suzuki H; Satomi T; Saruta E; Noguchi E
Jpn J Antibiot; 1980 May; 33(5):641-4. PubMed ID: 7001088
[No Abstract] [Full Text] [Related]
11. Degradable antimicrobial polycarbonates with unexpected activity and selectivity for treating multidrug-resistant Klebsiella pneumoniae lung infection in mice.
Yang C; Lou W; Zhong G; Lee A; Leong J; Chin W; Ding B; Bao C; Tan JPK; Pu Q; Gao S; Xu L; Hsu LY; Wu M; Hedrick JL; Fan W; Yang YY
Acta Biomater; 2019 Aug; 94():268-280. PubMed ID: 31129359
[TBL] [Abstract][Full Text] [Related]
12. The ability of airborne Klebsiella pneumoniae to colonize mouse lungs.
Bolister NJ; Johnson HE; Wathes CM
Epidemiol Infect; 1992 Aug; 109(1):121-31. PubMed ID: 1499666
[TBL] [Abstract][Full Text] [Related]
13. [Streptomycin and kanamycin level in the blood and lungs of guinea pigs when the antibiotics are administered by inhalation and intramuscularly].
Kozulitsyna TI; Dostavalova EP; Kozlova NV
Antibiotiki; 1975 Sep; (9):825-9. PubMed ID: 1180535
[TBL] [Abstract][Full Text] [Related]
14. Experience with amikacin and colistin in an outbreak of infection by resistant Klebsiella aerogenes.
Speller DC; Bint AJ; Stephens M
J Antimicrob Chemother; 1977 Sep; 3(5):483-91. PubMed ID: 332682
[No Abstract] [Full Text] [Related]
15. In vitro and in vivo morphological response of Klebsiella pneumoniae to cefotiam and cefazolin.
Nakao M; Nishi T; Tsuchiya K
Antimicrob Agents Chemother; 1981 May; 19(5):901-10. PubMed ID: 6271051
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy of beta-lactam and aminoglycoside antibiotics on experimental pneumonia caused by Klebsiella pneumoniae B-54 in diabetic mice.
Obana Y; Nishino T; Tanino T
J Antibiot (Tokyo); 1985 Jul; 38(7):941-7. PubMed ID: 3897162
[TBL] [Abstract][Full Text] [Related]
17. Infection of mice by aerosols of Klebsiella pneumoniae under hyperbaric conditions.
Heckly RJ; Chatigny MA; Dimmick RL
Appl Environ Microbiol; 1980 Jul; 40(1):80-3. PubMed ID: 6996616
[TBL] [Abstract][Full Text] [Related]
18. Effect of recombinant human interleukin-2 on the course of experimental chronic respiratory tract infection caused by Klebsiella pneumoniae in mice.
Iizawa Y; Nishi T; Kondo M; Tsuchiya K; Imada A
Infect Immun; 1988 Jan; 56(1):45-50. PubMed ID: 3275585
[TBL] [Abstract][Full Text] [Related]
19. Role of bacterial capsule in local and systemic inflammatory responses of mice during pulmonary infection with Klebsiella pneumoniae.
Yoshida K; Matsumoto T; Tateda K; Uchida K; Tsujimoto S; Yamaguchi K
J Med Microbiol; 2000 Nov; 49(11):1003-1010. PubMed ID: 11073154
[TBL] [Abstract][Full Text] [Related]
20. Application of S-thanatin, an antimicrobial peptide derived from thanatin, in mouse model of Klebsiella pneumoniae infection.
Wu G; Wu P; Xue X; Yan X; Liu S; Zhang C; Shen Z; Xi T
Peptides; 2013 Jul; 45():73-7. PubMed ID: 23643614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
